The sigma1 receptor is a target for the development of cardioprotective drugs

By afschroeder • October 10, 2025

Maslov LN, Tsirulnikov K, Slidnevskaya AS, Kilin M, Kan A, Grab AE, Gorbunov AS, Singh N. The σ₁receptor is a target for the development of cardioprotective drugs. Life Sci. 2025 Oct 9;381:124012. doi: 10.1016/j.lfs.2025.124012. Epub ahead of print. PMID: 41067303.

Tags: cardiac remodeling, heart, Ischemia/reperfusion;, mitochondria, Nephrology, Publications, sigma(1)-Receptor

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Heerspink HJL, Beernink JM, Agarwal R, Cherney DZI, Lam CSP, Neuen BL, Perkovic V, Tuttle KR, Sarafidis P, Birne R, Chen X, Hornum M, Maldonado[...]

Correction of Alkalemia in a Hemodialysis Patient: A Case Report

Luu YH, Hajmomenian HR, Khorsan R. Correction of Alkalemia in a Hemodialysis Patient: A Case Report. Cureus. 2026 Jul 28;18(7):e113556. doi: 10.7759/cureus.113556. PMID: 42666655; PMCID:[...]

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]